NYSEARCA:GNOMLI Global X Genomics & Biotechnology UCITs ETF (GNOMLI) Price, Holdings, & News → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free GNOMLI Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AAssets Under Management$1.57 millionDividend YieldN/ANet Expense Ratio0.00% Stock AnalysisStock Analysis Get Global X Genomics & Biotechnology UCITs ETF alerts: Email Address About Global X Genomics & Biotechnology UCITs ETFRead More Ad MillPub😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop! GNOMLI ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive GNOMLI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology UCITs ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details Issuer Fund NameGlobal X Genomics & Biotechnology UCITs ETF Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:GNOMLI Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings0 Fund Statistics Assets Under Management$1.57 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding SharesN/ABetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Ad MillPub😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop! Global X Genomics & Biotechnology UCITs ETF ExpensesTypeGNOMLINYSEARCA ETFsAll ETFsManagement Fee0.00%0.50%0.51%Other Expenses0.00%0.64%0.58%Total Expense0.00%0.74%0.70%Fee Waiver0.00%-0.68%-0.57%Net Expense0.00%0.58%0.58% Global X Genomics & Biotechnology UCITs ETF (GNOMLI) ExposureGNOMLI Sector ExposureGNOMLI Industry ExposureFull Holdings Details Similar ETFsiClima Climate Change Solutions ETFNYSEARCA:CLMATrend Aggregation Growth ETFNYSEARCA:TAAGProShares Ultra Communication Services Select SectorNYSEARCA:XCOMGlobal X Hydrogen UCITs ETFNYSEARCA:HYGNLIGrandeur Peak Global Explorer InstlNYSEARCA:GPGEX GNOMLI ETF - Frequently Asked Questions How do I buy shares of Global X Genomics & Biotechnology UCITs ETF? Shares of GNOMLI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:GNOMLI) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour bank is lying to you.MyBankTrackerForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology UCITs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
